Adventus Ventures

Adventus Ventures is a Sydney-based emerging venture capital firm focused on early-stage Australian and Asia-Pacific companies, with healthcare-relevant investments concentrated in medical devices and health IT software. Positioned as an operationally engaged early-stage investor, the firm targets technically differentiated companies that combine product novelty with the need for hands-on commercial guidance. Its healthcare exposure spans medical devices and MedTech alongside healthcare software, while the broader mandate extends to other technology categories serving regulated industries.

The firm invests at seed and Series A stages, writing checks typically in the $250,000 to $1M range. Geographic focus is concentrated in Australia, with selective participation in adjacent Asia-Pacific markets where Australian-headquartered companies expand. Adventus tends to participate in syndicated early rounds, sometimes leading at seed and acting as a meaningful syndicate member at Series A. The firm leans toward companies that combine clear technical differentiation, defensible IP, and scalable software or device economics, rather than service-heavy or clinically high-risk therapeutic plays.

For founders, Adventus represents domestic Australian early-stage capital with operational engagement on commercial strategy, product refinement, and team building. The firm is appropriate for medical device and health software companies based in Australia and pursuing both domestic and export market growth. Founders should expect an active investor relationship that includes board involvement, regular operational reviews, and structured guidance on customer development and regulatory positioning. The firm is less suited to capital-intensive clinical-stage therapeutics or to teams needing a US-based lead investor for global scaling. It fits best with founders seeking a substantive Australian institutional partner at the formative stages of company building.